ES551204A0 - Procedimiento para aislar derivados oxigenados de labdano a partir de coleus forskohlii - Google Patents

Procedimiento para aislar derivados oxigenados de labdano a partir de coleus forskohlii

Info

Publication number
ES551204A0
ES551204A0 ES551204A ES551204A ES551204A0 ES 551204 A0 ES551204 A0 ES 551204A0 ES 551204 A ES551204 A ES 551204A ES 551204 A ES551204 A ES 551204A ES 551204 A0 ES551204 A0 ES 551204A0
Authority
ES
Spain
Prior art keywords
labdane
procedure
coleus forskohlii
isolating oxygen
oxygen derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES551204A
Other languages
English (en)
Other versions
ES8705874A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES8705874A1 publication Critical patent/ES8705874A1/es
Publication of ES551204A0 publication Critical patent/ES551204A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
ES551204A 1985-01-26 1986-01-24 Procedimiento para aislar derivados oxigenados de labdano a partir de coleus forskohlii Expired ES8705874A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853502686 DE3502686A1 (de) 1985-01-26 1985-01-26 Verfahren zur herstellung von labdan-derivaten und ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
ES8705874A1 ES8705874A1 (es) 1987-05-16
ES551204A0 true ES551204A0 (es) 1987-05-16

Family

ID=6260904

Family Applications (1)

Application Number Title Priority Date Filing Date
ES551204A Expired ES8705874A1 (es) 1985-01-26 1986-01-24 Procedimiento para aislar derivados oxigenados de labdano a partir de coleus forskohlii

Country Status (9)

Country Link
US (1) US4724238A (es)
EP (1) EP0192056B1 (es)
JP (1) JPS61176585A (es)
AT (1) ATE44874T1 (es)
DE (2) DE3502686A1 (es)
ES (1) ES8705874A1 (es)
GR (1) GR860205B (es)
IE (1) IE860211L (es)
PT (1) PT81893B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963537A (en) * 1985-03-01 1990-10-16 Hoechst-Roussel Pharmaceuticals Inc. Labdane compounds, pharmaceutical compositions and use
US5130332A (en) * 1986-08-28 1992-07-14 Hoechst Roussel Pharmaceuticals Inc. Oxolabdanes
US5247097A (en) * 1986-08-28 1993-09-21 Hoechst-Roussel Pharmaceuticals Incorporated Oxolabdanes
US4978678A (en) * 1986-11-20 1990-12-18 Hoechst-Roussel Pharmaceuticals Inc. 12-halogenated forskolin derivatives
US5646175A (en) * 1987-12-28 1997-07-08 Hoechst Marion Roussel, Inc. Carbamoyloxylabdane compounds
US4920146A (en) * 1986-12-29 1990-04-24 Hoechst Roussel Pharmaceuticals Inc. Carbamoyloxylabdane compounds useful in reducing intraocular pressure
FR2613935B1 (fr) * 1987-04-15 1989-12-01 Roussel Uclaf Association renfermant a titre de principes actifs, un analgesique central et la forskoline
AT389114B (de) * 1987-10-08 1989-10-25 Hoechst Ag 7-acyloxy-6-aminoacyloxypolyoxylabdane und verfahren zu ihrer herstellung
US4883793A (en) * 1988-05-09 1989-11-28 Hoechst-Roussel Pharmaceuticals Inc. Hydrazinocarbonyloxylabdanes for treating cardiac failure
DE68902811D1 (de) * 1988-11-19 1992-10-15 Hoechst Ag Pharmazeutische zusammensetzungen mit einem gehalt an labdan-di-terpenoid-derivaten und pyrimido(6,1-a)isochinolin-4-on-derivaten und ihre anwendung.
US4999351A (en) * 1989-01-11 1991-03-12 Hoechst-Roussel Pharmaceuticals, Inc. 7-aryl and heteroaryl ethers of desacetylforskolin
US5177207A (en) * 1989-01-11 1993-01-05 Hoechst-Roussel Pharmaceuticals, Inc. 7-aryl and heteroaryl ethers of desacetylforskolin
IL89530A0 (en) * 1989-03-08 1989-09-10 Jeffrey J Feigenbaum Compositions containing forskolin
US5093336A (en) * 1989-07-06 1992-03-03 Hoechat-Roussel Pharmaceuticals, Inc. 6- and 7-deoxyforskolin and derivatives thereof
US5145855A (en) * 1989-07-06 1992-09-08 Hoechst Roussel Pharmaceuticals, Inc. 6- and 7-deoxyforskolin and derivatives thereof
DE10048596A1 (de) * 2000-09-30 2002-04-25 Henkel Kgaa Entzündungshemmende Wirkstoffe
US7240135B2 (en) 2004-03-05 2007-07-03 International Business Machines Corporation Method of balancing work load with prioritized tasks across a multitude of communication ports

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2557784C2 (de) * 1975-12-22 1986-04-17 Hoechst Ag, 6230 Frankfurt Forskolin, Verfahren zu dessen Gewinnung und diese Verbindung enthaltende pharmazeutische Präparate
IE43545B1 (en) * 1975-09-06 1981-03-25 Hoechst Ag Pharmacologically active substance obtainable from plants
AU2717777A (en) * 1976-07-21 1979-01-25 Hoechst Ag Pharmacologically effective substance from plants belonging to the family of labiatae
DE2640275A1 (de) * 1976-09-08 1978-03-09 Hoechst Ag Pharmakologisch wirksame substanz aus labiaten
DE2654796A1 (de) * 1976-12-03 1978-06-08 Hoechst Ag Polyoxygenierte labdan-derivate
US4517200A (en) * 1982-12-27 1985-05-14 Schering-Plough Corporation Method for treating allergic reactions with forskolin
US4564626A (en) * 1983-04-01 1986-01-14 Schering Corporation Methods of inducing bronchodilation
DE3314999A1 (de) * 1983-04-26 1985-03-14 Behringwerke Ag, 3550 Marburg Verwendung des diterpen-derivates forskolin zur immunstimulation
US4476140A (en) * 1983-05-16 1984-10-09 Yale University Composition and method for treatment of glaucoma
WO1985002616A1 (en) * 1983-12-14 1985-06-20 Brown University Research Foundation Treatment of metastasis

Also Published As

Publication number Publication date
PT81893B (pt) 1988-07-01
ES8705874A1 (es) 1987-05-16
US4724238A (en) 1988-02-09
IE860211L (en) 1986-07-26
EP0192056A1 (de) 1986-08-27
EP0192056B1 (de) 1989-07-26
GR860205B (en) 1986-05-21
ATE44874T1 (de) 1989-08-15
JPS61176585A (ja) 1986-08-08
DE3502686A1 (de) 1986-08-14
PT81893A (de) 1986-02-01
DE3664562D1 (en) 1989-08-31

Similar Documents

Publication Publication Date Title
ES551204A0 (es) Procedimiento para aislar derivados oxigenados de labdano a partir de coleus forskohlii
PT83647B (pt) Processo para a preparacao de novos derivados de benzimidazole com actividade farmacologica e de composicoes farmaceuticas que os contem
NO871408L (no) Forbedringer ved farmasoeytiske akseptable salter.
IE860077L (en) Glycosidic derivatives
DK92786A (da) Labdaner, fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
BR8704515A (pt) Derivados de piridinilpirimidina,processo para a producao dos mesmos e protetor de molestia de planta contendo tais derivados como o ingrediente ativo
PT92025A (pt) Processo para a preparacao de spiro-isoquinolina-pirrolidina-tetronas e seus analogos, uteis como inibidores da reductase da aldose
ES525786A0 (es) Un procedimiento para preparar derivados de pirazolo (3,4-b) piridina
DK144685A (da) Substituerede benzopyraner, fremgangsmaader til fremstilling deraf samt deres anvendelse i laegemidler
NO864108D0 (no) Fremgangsmaate for fremstilling av nye flavon-derivater.
FR2565825B1 (fr) Vaccin contre les maladies dues a des microorganismes tels que des mycoplasmes, sa preparation et membranes de microorganismes en tant que principe actif
MX9301235A (es) DERIVADOS 1,4-DIOXINO(2,3-B)PIRIDINA. á
MX163341A (es) N procedimiento para la preparacion de nuevas 1,4 dihidropiridinas,utiles como medicamentos antibioticos
DK0566567T3 (da) Antihypertensive benzopyranderivater
ES557370A0 (es) Procedimiento para preparar derivados de (dihidro-4,5-1h-imidazolil-2)-dihidro-2,3-indol
ES2020925B3 (es) Nuevas sales cristalinas de ariloxipropanolaminas, procedimiento para su preparacion y utilizacion de las mismas.
PT83269B (pt) Processo para a preparacao de derivados do acido 3-desmetil-mevalonico, de composicoes farmaceuticas que os contem bem como de intermediarios
ATE55985T1 (de) 4-benzyloxy-3-pyrrolin-2-on-1-yl-acetamid, dessen herstellung und verwendung.
DK257083A (da) Mikroorganismestammen chromobacterium violaceum, farmaceutisk aktive forbindelser fremstillet med stammen, fremgangsmaade til fremstilling af forbindelserne og disses anvendelse som laegemidler
PT84176B (pt) Processo para a preparacao de derivados de 2,6-dioxabiciclo {3.3.o7octano uteis como medicamentos
ES2039386T3 (es) Procedimiento para preparar oxolabdanos y su utilizacion para preparar medicamentos.
NO164660C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glycosidderivater.
NO860538L (no) Fremgangsmaate ved fremstilling av nye antiallergisk virksomme substanser.
ES2052483T1 (es) Nuevos derivados del 3,3,5-trimetilciclohexanol, su procedimiento de preparacion asi como las composiciones terapeuticas que los contienen.
NO169323C (no) Fremgangsmaate til fremstilling av en steril enhetsdoseform, av 7-(dimetylaminometylen)-amino-9a-metoksymitosan i glass

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970203